Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adicet Bio, Inc. (TORC) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adicet Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1720580.
Total stock buying since 2018: $45,238,179.
Total stock sales since 2018: $12,210,579.
Total stock option exercises since 2018: $208,095.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 6,250,000 | $15,000,000 | 5,900 | $8,437 | 0 | $0 |
| 2023 | 1,766,000 | $3,684,650 | 26,000 | $133,092 | 0 | $0 |
| 2022 | 0 | $0 | 74,877 | $1,334,521 | 18,988 | $166,407 |
| 2021 | 500,000 | $7,000,000 | 108,796 | $1,441,737 | 6,983 | $41,688 |
| 2019 | 0 | $0 | 7,680,700 | $9,292,792 | 0 | $0 |
| 2018 | 1,305,999 | $19,553,529 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-06 | 0 | $0 | 5,900 | $8,437 | 0 | $0 |
| 2024-01 | 6,250,000 | $15,000,000 | 0 | $0 | 0 | $0 |
| 2023-10 | 5,500 | $7,342 | 0 | $0 | 0 | $0 |
| 2023-09 | 5,500 | $7,810 | 11,000 | $15,290 | 0 | $0 |
| 2023-06 | 1,755,000 | $3,669,498 | 0 | $0 | 0 | $0 |
| 2023-02 | 0 | $0 | 15,000 | $117,802 | 0 | $0 |
| 2022-11 | 0 | $0 | 25,313 | $456,725 | 0 | $0 |
| 2022-10 | 0 | $0 | 9,713 | $156,598 | 3,388 | $25,003 |
| 2022-09 | 0 | $0 | 952 | $17,136 | 0 | $0 |
| 2022-08 | 0 | $0 | 13,936 | $241,371 | 0 | $0 |
| 2022-07 | 0 | $0 | 1,363 | $19,763 | 0 | $0 |
| 2022-04 | 0 | $0 | 15,600 | $327,600 | 15,600 | $141,404 |
| 2022-03 | 0 | $0 | 4,000 | $56,000 | 0 | $0 |
| 2022-02 | 0 | $0 | 4,000 | $59,328 | 0 | $0 |
| 2021-12 | 500,000 | $7,000,000 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 16,466 | $198,497 | 6,983 | $41,688 |
| 2021-05 | 0 | $0 | 26,466 | $367,760 | 0 | $0 |
| 2021-04 | 0 | $0 | 32,932 | $412,374 | 0 | $0 |
| 2021-03 | 0 | $0 | 32,932 | $463,106 | 0 | $0 |
| 2019-12 | 0 | $0 | 7,149,660 | $8,630,586 | 0 | $0 |
| 2019-11 | 0 | $0 | 531,040 | $662,206 | 0 | $0 |
| 2018-04 | 6,000 | $53,544 | 0 | $0 | 0 | $0 |
| 2018-01 | 1,299,999 | $19,499,985 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-05 | Kauffman Michael | Sale | 5,900 | 1.43 | 8,437 |
| 2024-01-25 | Orbimed Israel Biofund Gp Limited Partnership | Buy | 3,125,000 | 2.40 | 7,500,000 |
| 2024-01-25 | Gordon Carl L | Buy | 3,125,000 | 2.40 | 7,500,000 |
| 2023-10-02 | Schor Chen (President & CEO) | Buy | 5,500 | 1.33 | 7,342 |
| 2023-09-29 | Schor Chen (President & CEO) | Sale | 5,500 | 1.36 | 7,480 |
| 2023-09-28 | Schor Chen (President & CEO) | Buy | 5,500 | 1.42 | 7,810 |
| 2023-09-28 | Schor Chen (President & CEO) | Sale | 5,500 | 1.42 | 7,810 |
| 2023-06-30 | Dubin Steve (Director) | Buy | 5,000 | 2.40 | 12,000 |
| 2023-06-27 | Chimovits Erez | Buy | 875,000 | 2.09 | 1,828,749 |
| 2023-06-27 | Gordon Carl L | Buy | 875,000 | 2.09 | 1,828,749 |
| 2023-02-15 | Healey Don (Chief Technology Officer) | Sale | 4,533 | 7.57 | 34,328 |
| 2023-02-10 | Healey Don (Chief Technology Officer) | Sale | 10,467 | 7.97 | 83,474 |
| 2022-11-03 | Schor Chen (President & CEO) | Sale | 24,813 | 18.04 | 447,725 |
| 2022-11-02 | Schor Chen (President & CEO) | Sale | 500 | 18.00 | 9,000 |
| 2022-10-19 | Aftab Blake (Chief Scientific Officer) | Sale | 8,067 | 16.27 | 131,250 |
| 2022-10-12 | Aftab Blake (Chief Scientific Officer) | Sale | 1,646 | 15.40 | 25,348 |
| 2022-10-12 | Aftab Blake (Chief Scientific Officer) | Option Ex | 3,388 | 7.38 | 25,003 |
| 2022-09-14 | Schor Chen (President & CEO) | Sale | 952 | 18.00 | 17,136 |
| 2022-08-03 | Aftab Blake (Chief Scientific Officer) | Sale | 6,968 | 18.00 | 125,424 |
| 2022-08-01 | Aftab Blake (Chief Scientific Officer) | Sale | 6,968 | 16.64 | 115,947 |
| 2022-07-05 | Aftab Blake (Chief Scientific Officer) | Sale | 1,363 | 14.50 | 19,763 |
| 2022-04-04 | Galimi Francesco (SVP & Chief Medical Officer) | Sale | 7,979 | 21.00 | 167,559 |
| 2022-04-04 | Galimi Francesco (SVP & Chief Medical Officer) | Option Ex | 7,979 | 12.02 | 95,907 |
| 2022-04-01 | Galimi Francesco (SVP & Chief Medical Officer) | Sale | 7,621 | 21.00 | 160,041 |
| 2022-04-01 | Galimi Francesco (SVP & Chief Medical Officer) | Option Ex | 7,621 | 5.97 | 45,497 |
| 2022-03-09 | Jakobovits Aya (Director) | Sale | 4,000 | 14.00 | 56,000 |
| 2022-02-16 | Jakobovits Aya (Director) | Sale | 4,000 | 14.83 | 59,328 |
| 2021-12-08 | Sinclair Andrew | Buy | 500,000 | 14.00 | 7,000,000 |
| 2021-06-04 | Galimi Francesco (SVP & Chief Medical Officer) | Option Ex | 6,983 | 5.97 | 41,688 |
| 2021-06-03 | Schor Chen (President & CEO) | Sale | 16,466 | 12.05 | 198,497 |
| 2021-05-12 | Jakobovits Aya (Director) | Sale | 10,000 | 13.23 | 132,330 |
| 2021-05-05 | Schor Chen (President & CEO) | Sale | 16,466 | 14.30 | 235,430 |
| 2021-04-20 | Schor Chen (President and CEO) | Sale | 16,466 | 12.01 | 197,674 |
| 2021-04-06 | Schor Chen (President and CEO) | Sale | 16,466 | 13.04 | 214,700 |
| 2021-03-30 | Schor Chen (President and CEO) | Sale | 16,466 | 12.76 | 210,106 |
| 2021-03-16 | Schor Chen (President and CEO) | Sale | 16,466 | 15.37 | 253,000 |
| 2019-12-18 | Puretech Health Llc (10% Owner) | Sale | 6,161,531 | 1.20 | 7,393,837 |
| 2019-12-13 | Puretech Health Llc (10% Owner) | Sale | 205,763 | 1.24 | 255,763 |
| 2019-12-12 | Puretech Health Llc (10% Owner) | Sale | 385,884 | 1.25 | 482,355 |
| 2019-12-11 | Puretech Health Llc (10% Owner) | Sale | 59,921 | 1.25 | 74,901 |
| 2019-12-10 | Puretech Health Llc (10% Owner) | Sale | 336,561 | 1.26 | 423,730 |
| 2019-11-15 | Puretech Health Llc (10% Owner) | Sale | 531,040 | 1.25 | 662,206 |
| 2018-04-16 | Schor Chen (President and CEO) | Buy | 2,000 | 8.95 | 17,906 |
| 2018-04-11 | Schor Chen (President and CEO) | Buy | 2,000 | 9.36 | 18,724 |
| 2018-04-10 | Schor Chen (President and CEO) | Buy | 2,000 | 8.46 | 16,914 |
| 2018-01-30 | Puretech Health Llc (10% Owner) | Buy | 233,333 | 15.00 | 3,499,995 |
| 2018-01-30 | Orbimed Capital Gp Vi Llc (Director) | Buy | 533,333 | 15.00 | 7,999,995 |
| 2018-01-30 | Silverstein Jonathan (Director) | Buy | 533,333 | 15.00 | 7,999,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of TORC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adicet Bio, Inc. (symbol TORC, CIK number 1720580) see the Securities and Exchange Commission (SEC) website.